期刊文献+

microRNA在恶性肿瘤临床应用中的研究进展 被引量:3

Advance of microRNA in clinical application of cancer
暂未订购
导出
摘要 microRNA作为一种高效、稳定的非编码调控基因,参与了多种恶性肿瘤发生及发展。针对其机制的研究已取得重大进展,在此基础上,其临床应用也已成为当前肿瘤研究热点之一。研究显示,microR-NA具有作为恶性肿瘤早期诊断、治疗及预后标志物的潜力,这为其临床应用打下了坚实的基础。 As a kind of stable non-coding RNA with high efficient,MicroRNAs take important role in carcinogenesis and tumor development.In past few years,the mechanism of MicroRNAs in carcinogenesis has gotten significant progress.Meanwhile,the studies of MicroRNAs in clinical application are also undergoing.Previous studies showed that MicroRNAs had great potential in cancer early detection,treatment and prognosis as a tumormarker.
作者 马强 姚煜
出处 《现代肿瘤医学》 CAS 2012年第4期835-838,共4页 Journal of Modern Oncology
基金 宁夏卫生厅重点科研课题(编号:2009089) 陕西省科技攻关资助项目(编号:2010kw-17)
关键词 MICRORNA 恶性肿瘤 临床应用 microRNA cancer clinical application
  • 相关文献

参考文献29

  • 1Cho WCS. microRNAs:Potential biomarkers for cancer diagnosis,prognosis and targets for therapy[J].International Journal of Biochemistry & Cell Biology,2010,(08):1273-1281.
  • 2Ferracin M,Veronese A,Negrini M. Micromarkers:miRNAs in cancer diagnosis and prognosis[J].Expert Review of Molecular Diagnostics,2010,(03):297-308.
  • 3Lawrie CH,Gal S,Dunlop HM. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J].British Journal of Haematology,2008,(05):672-675.
  • 4Gui JH,Tian YP,Wen XY. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies[J].Clinical Science(London),2011,(5-6):183-193.
  • 5Baraniskin A,Kuhnhenn J,Schlegel U. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system[J].Blood,2011,(11):3140-3146.
  • 6Hanke M,Hoefig K,Merz H. A robust methodology to study urine microRNA as tumor marker:microRNA-126 and microRNA-182 are related to urinary bladder cancer[J].Urologic Oncology,2010,(06):655-661.
  • 7Yu L,Todd NW,Xing LX. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers[J].International Journal of Cancer,2010,(12):2870-2878.
  • 8Miyachi M,Tsuchiya K,Yoshida H. Circulating musclespecific microRNA,miR-206,as a potential diagnostic marker for rhabdomyosarcoma[J].Biochemical and Biophysical Research Communications,2010,(01):89-93.
  • 9Hausler SFM,Keller A,Chandran PA. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening[J].British Journal of Cancer,2010,(05):693-700.
  • 10Xing LX,Todd NW,Yu L. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers[J].Modern Pathology,2010,(08):1157-1164.

同被引文献32

  • 1Hatzimichael E, Dasoula A, Benetatos L, et al. Study of specific ge- netic and epigenetic variables in multiple myeloma[J ]. Leuk Lym- phoma,2010,51 (12) : 2270 - 2274.
  • 2Garzon R, Fabbri M, Cimmino A, et al. MicroRNA expression and function in cancer [ J ]. Trends Mol Med, 2006,12 ( 12 ) : 580 - 587.
  • 3Sayed D, Abdellatif M. MicroRNAs in development and disease [ J]. Physiol Rev,2011,1 (3) :827 - 887.
  • 4Xu J, Wu C, Che X, et al. Circulating microRNAs, miR - 21, miR - 122, and miR - 223, in patients with hepatocellular carcinoma or chronic hepatitis [ J ]. Mol Carcinog,2011,50 : 136 - 142.
  • 5Sehmittgen TD, Livak KJ. Analyzing real - time PCR data by the comparative CT method [ J ]. Nat Protoc,2008,3 (6) : 1101 - 1108.
  • 6Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large B -cell lymphoro[J]. Br J Haemato1,2008,141:672 -675.
  • 7Asaga S, Kuo C, Nguyen T, et al. Direct serum assay for microRNA -21 concentrations irl early and advanced breast cancer[J]. Elin Chem ,2011,57 ..84 -91.
  • 8Pichiorri F, Suh SS, Ladetto M, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis [ J ]. Proc Natl Acad Sci USA,2008,105:12885 - 12890.
  • 9Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012, 62(1) : 10 -29.
  • 10Chandramouli A, Onyeagucha BC, Mercado - Pimentel ME, et al. MicreRNA - 101 ( miR - IO1) post - transcriptionally regulates the expression of EP4 receptor in colon cancers [J].Cancer BioI Ther, 2012, 13(3): 175-183.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部